HEALTH● LOWJul 24 · Jul 24, 2026, 9:40 PM
CEPI begins first human trial of Bundibugyo Ebola vaccine
Premium Times
The Phase I clinical trial, known as BD-Ebov, will evaluate the safety of the experimental vaccine and its ability to stimulate immune responses in healthy adult volunteers. The post CEPI begins first human trial of Bundibugyo Ebola vaccine appeared first on Premium Times Nigeria.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH30m agoOne in three young adults use AI chatbots for drug and alcohol information, study findsEuroNews [en]HEALTH1h agoEBOLA: The Bundibugyo Strain Does Not Show Symptoms Early In Patients, Virologist WarnsChannels TVHEALTH1h agoEbola: FG confirms evacuation of Nigeria’s index patient, husband to SwitzerlandVanguard NigeriaHEALTHBREAKING1h agoEbola: Suspected index patient evacuated from Nigeria by air ambulance – ReportVanguard Nigeria